Lifeboat Foundation

Meta has yet to go above $1 trillion, despite recently pivoting to generative AI.

A team of Japanese researchers has made a groundbreaking discovery in the field of plant communication, capturing real-time footage of plants transmitting defense responses to their neighbors.

This significant achievement, led by molecular biologist Masatsugu Toyota from Saitama University, was published in the journal Nature Communications.

The study’s breakthrough lies in observing undamaged plants responding to volatile organic compounds (VOCs) emitted by other plants experiencing mechanical damage or insect attacks.

Water might’ve existed in the building blocks of our world.

The study hypothesizes that ‘pre-digested’ foods contributed to the development of larger brains. The large, capable human brain is a marvel of evolution, but how it evolved from a smaller primate brain into the creative, complex organ of today is a mystery. Scientists can pinpoint when our evolutionary ancestors evolved larger brains, which roughly tripled in size as human ancestors evolved from the bipedal primates known as Australopithecines.

Short, toxic RNAs kill brain cells and may allow Alzheimer’s to develop.

The quake was at a depth of 10 km (6.21 miles), GFZ said.

A non-volatile version could be on its way, too.

Cedars-Sinai Cancer investigators have used a unique precision medicine and artificial intelligence (AI) tool called the Molecular Twin Precision Oncology Platform to identify biomarkers that outperform the standard test for predicting pancreatic cancer survival. Their study, published in Nature Cancer, demonstrates the viability of a tool that could one day guide and improve treatment for all cancer patients.

“Molecular Twin, which we developed at Cedars-Sinai, can be used to study any tumor type, including pancreatic cancer, which is notoriously difficult to treat,” said Dan Theodorescu, MD, Ph.D., director of Cedars-Sinai Cancer and the PHASE ONE Foundation Distinguished Chair, and senior author of the study. “Using our Molecular Twin technology, we anticipate creating tests that can be used even in locations that lack access to advanced resources and technology, pairing patients with the most effective therapies and expanding the availability of precision medicine.”

Investigators used the Molecular Twin platform to analyze blood and tissue samples from 74 patients with the most common and most aggressive pancreatic cancer type, pancreatic ductal adenocarcinoma. The disease begins in the cells lining ducts that carry digestive enzymes from the pancreas to the small intestine.

We can live forever, but it’s nothing like what we imagined.